These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 11473107)

  • 1. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
    Phiel CJ; Zhang F; Huang EY; Guenther MG; Lazar MA; Klein PS
    J Biol Chem; 2001 Sep; 276(39):36734-41. PubMed ID: 11473107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
    Leng Y; Chuang DM
    J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
    Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
    Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common mechanism of action for three mood-stabilizing drugs.
    Williams RS; Cheng L; Mudge AW; Harwood AJ
    Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
    Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
    J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.
    Jeong MR; Hashimoto R; Senatorov VV; Fujimaki K; Ren M; Lee MS; Chuang DM
    FEBS Lett; 2003 May; 542(1-3):74-8. PubMed ID: 12729901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.
    Balasubramanian D; Deng AX; Doudney K; Hampton MB; Kennedy MA
    Neuropharmacology; 2015 Dec; 99():79-88. PubMed ID: 26151765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
    Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
    J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase.
    Wu G; Nan C; Rollo JC; Huang X; Tian J
    J Biomed Sci; 2010 Mar; 17(1):16. PubMed ID: 20219112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
    Shi Y; Gerritsma D; Bowes AJ; Capretta A; Werstuck GH
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4491-4. PubMed ID: 17566732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
    Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
    Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
    Gurvich N; Berman MG; Wittner BS; Gentleman RC; Klein PS; Green JB
    FASEB J; 2005 Jul; 19(9):1166-8. PubMed ID: 15901671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3.
    Leng Y; Wang J; Wang Z; Liao HM; Wei M; Leeds P; Chuang DM
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
    Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
    Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
    Gurvich N; Klein PS
    Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.